Glucagon-Like Peptide-1 Receptor Agonists Decrease Medical and Surgical Complications in Morbidly Obese Patients Undergoing Primary TKA

Abstract

Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.